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The biochctnicul properties of the pS1 subunit of HIV-I reverse trtinscriptiisc (RT) wcrc studied in order to understand its role in the heterodimcric 
form ~661~5 I found in virions. A rccombinunt form of RT, p5 l/p5 I 1 expressed in yeast. was puriticd and characterized. The cnzymc was affinity 
ltibelcd using ;L 5’ modified oligonuclcotidu primer. covtilcntly linked. that was further cbngdtcd in the presence of a radioactive dNTP precursor. 
WC found that the p5l subunit was lubrlcd in the p51ipSi form, thus xflccting its activity. while this subunit WYLS mtalytically silent in the 
helcrodimer, since only the ~66 subunit was labclcd in ~hc luttcr recombinant form. Proccssivity studies showed long&cd products synthesized 
by ~511~5 I, ;I’; in the USC of the other RT forms. 1 hc cffcct of primer tRNAl-” on ~hc pSl/pSl activity showed a strong inhibitory effect in the 
abscncc of KCI. similur to that obscrvcd with 11x p661pSl form. while the smw p5l/pSl enzyme was strongly stimulated by tRNAL”. like RT 
p66/p6G. when KCI was prcscnt in the incubation mixture. 
Rcvcrse transcriptuse: Rccombinunt form: p5I subunit: Affinity lubuling: Primer tRNA interaction: HIV-I 
I. INTRODUCTION 
Human immunodeficicncy virus type- I reverse tran- 
scriptase (HIV- I RT) is an enzyme playing a crucial role 
in the replication of this human retrovirus (for a recent 
review see [l]). As with other rctroviral RTs, this DNA 
polymerase isable to catalyze three reactions, all essen- 
tial, to transform the single-stranded retroviral RNA 
genome into double-stranded proviril DNA: polymeri- 
zation of a DNA strand complementary to the retrovi- 
ral genomic RNA template, hydrolysis of the RNA moi- 
ety of the DNA-RNA hybrid (RNAse H activity) and 
synthesis of the second DNA strand. In virions, HIV-I 
RT is thought to occur as a dimer containing polypcp 
tides of M, 66,000 and 51,000 (p6G and ~51, respec- 
tively) at a molar ratio of 1: I. The two po1ypeptides arc 
identical except hat p5l is deprived at its C-end of a 
fragment of M, 15,000 corresponding to the RNAse H 
domain of the enzyme, Very little is known either about 
the protein-protein interactions that govern dimer for- 
mation, or the role of ~51 in the heterodimeric enzyme. 
The idea that ~66, which contains the DNA polymerase 
and RNAse H domains of the enzyme, constitutes the _ 
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catalytic subunit has been accepted, while no function 
has been proposed for ~51. Although this subunit has 
the DNA polymerase domain several reports have indi- 
cated that purified pSl/pSl was either inactive or had 
very low levels of DNA po!ymerase activity 12-61. Other 
reports, however, have shown its activity through acti- 
vated gel analysis of the viral enzyme [7] or in recombi- 
nant RT [B-lo]. More recently. Le Gricc et al. showed 
that wild-type p51 RT failed to restore activity to a 
heterodimer whose ~66 subunit was mutated [1 I]. Thus, 
if the catalytic ability of p66 seems clear, the role of the 
~51 subunit has not been established. 
Our aim is to study the mechanism of action of HIV-l 
RT with a special emphasis on the initiation step of 
cDNA synthesis, as well as the search of specific inhib- 
itors of this enzyme. For this purpose we started work- 
ing on the interactions of RT with its specific natural 
primer, tRNA‘y”. Using different approaches we 
showed complex formation between a recombinant 
form of HIV-l RT and bovine tRNALY” [12], as well as 
the sign&ant structural changes in the enzyme con- 
formation induced by complex formation with primer 
tRNA [ 131. While testing the initiation ofcDNA synthe- 
sis from tRNALY” annealed to a fragment of viral RNA 
carrying the primer binding site (PBS). we observed that 
the p66/p51 form of the enzyme was strongly inhibited 
by the slightest excess of free tRNALY’ [14]. More re- 
cently we showed that the p66/p66 form of the enzyme 
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produced in a protcasc deficient yeast strain was stimw- 
lated by tRNA under conditions where the hcterodi- 
merit enzyme p66/p51 was shown previously to be 
strongly inhibited, Both activities. DNA polymerase 
and RNAse H, carried by the p66 form were affected 
similarly (Alldreola et al., submitted for publication). 
III this article we have attempted to study the role of 
the ~51 subunit by characterizing the DNA polymcrasc 
activity of the homodimeric form p5l/pSl. WC show 
that significant activity is present in this recombinant 
protein. Moreover, we describe the effect oftRNALY” on 
the DNA polymerue activity of p5l/p5 I, as well us the 
ability of p51/p51, p66/p66 and p66/p5 1lo initiate DNA 
synthesis from a primer covalently attached to the cor- 
responding polypeptidcs by affinity labeling. 
2, MATERIALS AND METHODS 
Unliibclcd nuclcotidcs. oligonuclcolidcs or polynuclcotidcs wcrc 
oblilincd from Sigmn or Ph:lrmucia. L’H]dTTP w;~s purchoscd from 
Commissuriat ii I’Encryic Atomiquc-Sxluy (CEA-Fruncc) or Amor- 
sham (UK,. DEAE-Trisacrvl M W;IS from IBF. nhosohoccllulosc P-1 1 
I 
I’rom Whntmiln. MOTTO S HI< 95 from Pharmkiit. hcp;trin-ilgarosc 
from Sigmn. Aprotinin. Icupcptin. pcpstillin A were from Signlit. 
Phcnyl mctlrnnc sulphonyl Iluoridc (PMSF) wus from Bochringcr ~uid 
bcnzrmidinc l’rom Fluk;~, The oligonuclcolidc (PA),, \vils obtained by 
liydrolysis ol’ poly rA using 111~ cndonuclc;lsc from snukc VL’IIOIII 01’ 
rhjr /rr/ju dn/ta [ 151. 
hol d~hydro~c~~i~sc~2;glycer~~l~icl~ydc~~-~~~osp~~~~tc dch&lrogcn;lsc 
(ADH2IGAP) hubrid nromotcr hnvc been dcscribcd 1161. For con- .- . . a 
struction ot’thc RTS gcnc encoding mine acids l’ro’5” to Lcu”~ ol’~hc 
HIV-I pal open reatling frtunc. I~W previously dcscribcd RT4 gcnc [ 171 
wils modified using synthetic oligonuclcolidcs, The 78mcr duplex in- 
cludcd the restriction cnzymc k/1718 ttirgct she nl amino ;lcid Trp’+“’ 
;md :I SI//I site in1mcdi;ucly following the termination codon [S], Oligo- 
nuclcotidcs wcrc synthesized by the phosphorumiditc method using iln 
Applied Biosystcms 380A DNA synthesizer. 
The HIV-I RT p661pSI Wns obtained 21s dcscribcd bclbrc [I?], RT 
p661pG6 ;md p5 l/p51 were puriticd ;I:; dcscribcd Ibr IIIC hctcrodimcric 
form but using n protatsc*dcficicnt ycust Slrnin (JSC 302. dcriv::livc 
ofAB lIB:Mata.Icu?.trp-l,ura3-52.prBl-ll2?,pcp4-3,prCl-407 
[cir”] ttxnsformcd cilhcr with the cxprossion vector pRS??RTS 01 
pBS24RT6. rcspcclivcly) [5]. During the extraction and the purifkt- 
lion of the enrymc the following prolcinasc inhibilors wcrc used: I 
mM PMSF. I pg/ml cuch oftiprotinin. Icupcptin nnd pcpstlrtin A itnd 
0.5 mM bcnzumidinc, 
2.4. Pw~l:icrr~iur~ q/'hdtrr~ rRh'A.r 
tRNAs from beef liver wcrc purified ;LS dcscribcd bcforc [Id]. 
The rcxtion mixture conttiincd in il fkd volume 01’0.05 ml. 50 mM 
Tris-HCI. pH 8.0. 5 mM MgCI,, IO mM dithiothrcitol. 0.48 OD2,,,Jml 
poly(rA),oligo(dT) (5: I), 0.5-l PCi I’HJdlTP (56 Ci/mmol). SO PM 
dTTP :tnd cnzymc ;IS indicutcd. 80 mM KCI was used for pbB/p5 I und 
p66/p66. while no KCI was prcsunt in the ussay ol’p5l/pSl, Incubation 
W;IS carried out ut 37°C Ibr various times. Rcxtions wcrc stopped by 
the addition of I ml ol’cold 10% trichloroucclic acid plus 0, I M sodium 
pyrophosphalc. The prccipitntcs wcrc lilicrcd through nitroccllulosc 
mcmbrimcs, wnshcd wiih 2% trichloroxctic acid, dried and counted 
in il PPO/POPOPllolucnc scintillation mixture. 
Product nn;llysis: ~hc reaction mixture. incubtitcd nt 3O”C, con- 
t;lincd 50 niM Tris-HCI. pH 8.0, IO n1M dithiothrcik~l. 5 mM MgCL. 
SO tuM KCI (p6GIpSI and p66/p66) ;md no KCI Ibr pSl/pSl, 0.48 
OD,,jml poly(rA)‘(JT),,I and IO PCi a+“P]dTTP (3.000 Ci/mmol). 
Alicr ;I pulse of 5 Knin. 100 PM dTTP wtis added nnd tl1c rcaclion 
procccdcd I’or dilI&cn~ lcng~hs 01’ time. The rcactlon wu stopped by 
the addition of I2 mM EDTA :md 0.1% SDS. The products wcrc 
phcnol~cxtrxtcd nnd prscipitatcd with C~IIIOI. Sumplcs were rcsus- 
pcndcd in s;unplc bulkr: TBE (100 mM Tris-HCI. pH 8.3. 0.083 M 
bar;tle and 2 mM EDTA) plus 10% plyccrol, 110% dcionioed for- 
mimlidc. 0. I% xylcnc cyanoi and 0. I % Bromophcnol blue. Migration 
hulk wns TBE. Elcctrophorcsis wns pcrl‘orr?xd on :t 14% polyucryl- 
umidc pcl in ihc prcscncc 01’8 M urcit ror 3.5 h iIt 20 V/cm, The gel 
WiIs thc~~ subniittcd to ;lutoradiogr~iphy 011 3MR fil~m, 
The rc:tction mixture conttiinillg in :I lin:d volume 01’ 15-25 ul. IX 
mM Tris-HCI. pH 8.0. IO n1M Mg XCIU, I ,u.M RT, p(A),, HS 
tcmpl;i~c and un oligo~hymidyln~c analog modilicd ;II its 5’ end :IS 
primer (the dctiiilcd proccdurc ol’synthcsis nnd tIllinily Iubcling with 
this ;IKI~O~ will bc dcscribcd elscwhcrc) Wils incubittcd for 2 h nt 3O”C, 
The covalcn~ binding ol‘ primer to c11zymc was slilbilizcd by ttddiiion 
ol’un cxccss ol’ NaBHA (5 IIIM) ilnd dithiothrcitol (0.75 mM). Alicr 20 
min ~II 0°C. folluwcd by an incub:liion 01’ 20 min ut 30°C ~hc poly- 
mcrizi~tion rcxtion wi\s sinrtcd by addition of IO@i ol’a-[“‘P]dTTP, 
Primer clonyation W:IS done for 90 min ;II 30°C. Sq~lcs were then 
submitlcd to SDS-PAGE (I?% ocrylumide). Alicr ~lccwophore~ic mi- 
gration the gel wits st;lincd wilh Coom;lssic brilliunt blue. dried ;~nd 
submiltcd to autoradiogruphy on 3MR liltns. 
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Fig. I, (A) Purification or the three forms of HIV-I RT. One unit of 
rnrymc activity is dcfincd ns that timount cutulyzing the incorporation 
ol’l nmol ol’[‘H]dTMP/h itt 37°C. Assuys were performed us dcscribcd 
in SCCI~OII 2. (B) SDS-PAGE of puriticd RT pSl/pSI (lane I) und 
~661~51 (lnnc 2). Prolcins were stnincd with Coomassic blue, (C) 
Wcslcrn blot analysis of IIIL’ three lbrms of HIV-1 RT. Immunoblot- 
tiny W:IS pcrformcd :IS dcscrihcd in [14]. L:mc 3. p6G/p66; lane 4. 
pGb/p51; and lunc 5. pSl/pSl, 
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3. RESULTS AND DISCUSSION 
As stated above, virions of HIV-l contain approxi- 
mately equal amounts of the two reverse transcriptasc 
polypeptides. pG6 and ~51. The presence of thcsc two 
pcptides in cquimolar amounts has led to the assump 
tion that the enzyme found in the virions is a hctcro- 
dimer. Interestingly, in uvian retroviruscs. reverse tran- 
scriptase is also a heterodimer complex; however, in this 
case the catalytic subunit is the smaller polypeptide (tl 
subunit) which possesses both DNA polymerase and 
RNAse H activities, while subunit /I. which still pos- 
sesses the integrasc domain, has very low catalytic activ- 
ity and seems to be involved in the recognition of the 
specific primer tRNA [IS]. In the case of HIV-I the 
polypeptide possessing the integrase activity is found in 
the virions as an independent protein of A/r, 32,000. 
Recombinant proteins have been cxtcnsively used for 
the study of this viral polymcrwse given the safety risks 
of manipulating highly pathogenic agents and the very 
low yield of rcvcrse transcriptase when purification is 
attempted from virions. Although some of the expres- 
sion systems ilsed arc able to produce the hctcrodimer. 
most of ihr work reported has been performed with 
expression systems that produce the homodimcr pG6/ 
~66. Data obtriined with the p66/p66 form ;irc very 
useful to study the catalytical propcrtics of HIV-I RT. 
because the DNA polyrnerase domain is essentially 
identical in the ~661~66 and in ~hc pGBlp5 I forms. How- 
ever, the nearest lhe chosen target is (in this case HIV- I 
RT) to the heterodimeric enzyme found in virions, the 
best equivalences will be obtained between in vitro and 
in vivo cxperimcnts. As stated above. different groups 
have reported that the ~51 chain was either inactive in 
DNA polymerization. had very low levels of activity OI 
was weakly active as a loosely associated imcr. Thus, 
the question remains open concerning the role 0r the 
~51 subunit in the mature retroviral polymcrasc. 
In order to answer this qucstio!l we have tried to 
further characterize the ~51 subunit of HIV-I RT. WC 
expressed this protein by transforming protease defi- 
cient yeast cells with a plasmid containing the reverse 
transcripiase gene deleted of its C-end in the domain 
attributed to Ihc RNAse H activity. Purification of p66/ 
~51, p66/p66 and ~511~51 recombinant forms was per- 
formed through several chromatographic steps as de- 
scribed before [ 1X14]. The summary of the purification 
procedure for the three recombinant proteins is shown 
in Fig. IA. The two homodimers howed a lower, but 
important, specific activity when compared with that of 
the ~661~51 form. The degree of purification to ap- 
parent homogeneity of these enzymatic forms was very 
similar (Fig. IA). Immunoblotting using antibodies 
raised against pGBlp5 I, obtained as described before 
[12-141, showed a positive reaction with polypeptidcs 
identical to those revealed by staining (Fig. I B). It is 
worth mentioning that to measure the activity of RT 
100 200 
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Fig. 2. (A) Aetivityol’RTp66lpSI and pSl/pSI L~S;L t-unction ofprotcin 
conccntr~tion. Dilkrcm conccntruions of RT #WpSI (c)or @l/p51 
(0) wcrc’ ;Issilycd 3s dcscribcd in suction 1. Incubation WBS for 10 min 
;II 37°C. Eilkx of KCI OII hc activity of (6) RT p66/pSl (0) or (C) 
p66/p66 (a) and pSl/pSl (0). The conccnmtion of RT in each cast 
WIS 31 nM p66lpSI. 30 IIM p66/p66 und 39 nM pSl/p51. 
pSi/pSi iiifkreni faciors must bc considcrcd. First. the 
non-linearity in cDNA synthesis when important dilu- 
tions of the enzyme were used impaired an accurate 
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assay. As shown in Fig .2A. RT p51/p51 must be rather 
concentrated in the enzymatic test (100 rig/assay)) to
obtain linearity as a function of protein concentration, 
while RT ~661~51 can be diluted in the same range 
without loosing its activity (I-2 ng/assay). Second, the 
strong inhibition of this enzyme by salt led us to eli- 
minate KC1 from all dialysis during the purification 
procedure and from the enzymatic test. In fact a striking 
difference between the pSl/p51 and the two other re- 
combinant forms of HIV-l RT is the effect of KC1 on 
these proteins. As seen in Fig. X3 the ~661~51 form is 
strongly stimulated by KCl, the ~661~66 homodimer is 
not affected by salt and the p5 I /p5 1 enzyme activity is 
extremely sensitive to KCI (Fig. 2C). This property of 
RT p5l/p51 may explain the previous claims of other 
groups, who assayed the enzyme in the presence of salt, 
concerning the lack or very low activity of the ~511~51 
recombinant form. Similar sensitivity of the pSl/pSl 
form was observed with urea: the p66/p51 and ~661~66 
forms were not affected by urea at final concentrations 
higher than 2 M, while the ~511~51 form was 50% in- 
hibited at 0.5 M urea (data not shown). It has been 
reported that dimer association in the case of the ~511 
p5l is much weaker than in the case of the two other 
recombinant forms [19]. Thus, we explored the possibil- 
ity that the inhibitory effect of KCI was due to the 
monomerization, and hence inactivation of the enzyme, 
since it has been reported that both p66 and ~51 mo- 
nomers are catalytically inert [9]. Not shown are results 
indicating that after molecular filtration on an AcA 44 
ultrogel column in the presence of 0.1 M KCI. the p51/ 
p5 1 form is completely inactivated, although more than 
50% of the enzyme eluted as a dimer when followed by 
its reaction with the anti-RT IgG. 
These results indicate that HIV-l RT ~511~51 pos- 
sesses a DNA polymerase domain with a significant 
degree of activity provided that the assay is performed 
under the appropriate conditions. The effect of strong 
inhibitors of reverse trasncriptase, like AZTI’P, ddTTP 
and TIBO (Pharmatex, NJ, USA), showed no signifi- 
cant differences between the ~661~5 1, ~661~66 and p51/ 
~51, except in the case of ddTTP which inhibited the 
p5l/p51 to a lesser extent than the two other recom- 
binant enzymes (results not shown). 
Next we tried to answer the question whether the 
catalytic ability of the ~51 subunit can operate in both 
dimeric forms. For this purpose each one of the RT 
forms was covalently bound to an oxidized primer ana- 
log of oligo dT modified at its 5’ end, After reduction 
with NaBH1, to stabilize the complex formed between 
the enzyme and this modified primer, cz- r’P]dTTP and 
the other components of the incubation mixture neces- 
sary for cDNA synthesis were added. Incorporation of 
the dTMP residue was evidenced after SDS-PAGE and 
autoradiography. As it can be seen in Fig. 3A the p66 
band of the heterodimer is labeled, while the ~51 sub- 
unit showed no elongated primer. As expected. radioac- 
26 
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Fig. 3, (A) Affinity labeling of the three forms of RT. The reaction of 
labeling was done us described in section 2. using I ,uM of RT. Lane 
I, ~661~5 I : lunc 2, pWpG6: lane 3, pS l/p5 I : lane 4, Qume as lunc I, 
but no (PA),, template was prcscnt during the covalent binding of 
primer analog. (B) Analysis of the products synthesized by the three 
forms of RT. The cnzymcs wcrc incubated in the conditions described 
in section 2. After a pulse of 5 min (I;uncs 1. 6 and I I). IOO,UM dTTP 
was added and the reaction procuedcd for IO min (lam 2. 7 and 12). 
20 min (lanes 3. 8 and 13). 30 min (lanes 4.9 and 14) and 60 min (lanes 
5, IO and IS). Lane M. oligonuclcotidc sizing markers oT L1 to 32 ixscs 
(Philrmacia) labeled in 5’ with p[“‘P]ATP (Pharmaciu) were used. 
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oI’LRNA on the aclivity ol’RT pSl/pSl. (A) 39 nM RT 
prc-incubated Ibr I5 min ;II 37°C in tllc prcsc!lsc of 
ditl‘crcnt conccnuxlions ol’tRNA’+ (0). tRNATrJ’(o)or tRNA’“‘(A). 
Alicr the prc-incubaiion, the activity of pSlip51 was IncaWed ils 
dcscribcd in scclion 2. (13) Same ils in A. but KCI (80 mM) was prcscnl 
when measuring ~hc acliviiy or RT pSl/pSI. 
tivity in the p66/p66 forln was confined to the high 
molecular weight subunit. while the PSI subunit was 
labeled in the lane corresponding to the p5l/p51 form. 
No labeling was obtained when the modifying reaction 
was done in the absence of template (Fig, 3A, lane 4). 
Thus, our results clearly indicate that the p5l subunit, 
although active as a homodimcr, is catalytically silent 
in the mature form of HIV-I RT. An interesting possi- 
bility opened by this approach is the fact that we have 
labeled the ‘active’ primer binding site of the enzyme. 
Further work is under progress to localize and sequence 
the peptide fragment of HIV- I RT corresponding to this 
active site. This approach, in the absence of a crystallo- 
graphic clear structure of the DNA polymerase domain 
of the enzyme, will help to get a clear picture of the 
topography of interactions between RT and its sub- 
strates. 
In spite of the set of properties of pSl/p51 described 
above the question about the role of the p5l subunit in 
the HIV-I RT hetcrodimer is still unanswered. The 
processivity of DNA polymerases, i.e. the ability to syn- 
thesize long stretches of DNA without dissociating from 
the template-primer complex, is an important parame- 
ter governing the function of these enzymes. Results 
shown in Fig. 3B indicate that the processivity of HI’V-I 
RT during DNA synthesis using a poly(rA).oligo dT 
templateaprimer system is essentially the same 
in the three recombinant forms. Thus, we have shown 
not only that the DNA polymerase activity of the p51/ 
p5l form is significantly high, but that the size of the 
cDNA products synthesizing by this recombinant pro- 
tein is similar to that obtained using the p66/p51 and 
~661~66 forms. 
An interesting possibility that dcscrvcs to bc explored 
is a possible role of the p5l subunit on tRNA recogni- 
tion. as it has been shown for thej3 subunit of the avian 
retroviral RTs [ 181. All known reverse transcriptases 
use a host tRNA as the specific primer for the synthesis 
of the first strand of DNA. Evidence from our labo- 
ratory and others [20-231 has shown that reverse tran- 
scriptase is involved in the selection of the specific 
primer from the pool of total cellular tRNAs and it is. 
at least in part. involved in the annealing of the primer 
tRNA to the complementary egion, PBS, in the retro- 
viral genome [24.25]. In previous articles we have shown 
that the p66/pSl form of HIV RT can form a stable 
complex with bovine tRNALY” and that the heterodi- 
merit form of HIV-I RT can be inhibited by its primer 
tRNA [l3.13]. Nuclease digestion of tRNA’-Y” allowed 
us to localize the anticodon region as the probdbk ori- 
gin of the inhibitory effect [141. Recently we have shown 
that the homodimer p66/p66 was able to form a com- 
plex with tRNALr”; the interaction with primer tRNA 
was confirmed by the fact that the HIV-I RT ~66 form 
was strongly stimulated by tRNALy” under conditions 
where the p66/p51 form was inhibited (Andreola et al., 
submitted for publication). A similar approach was 
used in this article with the pSl/pSI recombinant form. 
The effect of tRNALr” on RT p51/p5l was performed 
in the presence or absence of KCI. Results under these 
two conditions were diametrically opposed: tRNALy’ 
and tRNATrp strongly inhibited the activity of the ~511 
p5l homodimcr in the absence of KCI (Fig. 4A). while 
a stimulation of this recombinant enzyme form was 
obtained when DNA synthesis was assayed in the pres- 
ence of salt (Fig. 4B). No effect was observed with 
tRNA”“i. as has been described before for the other 
recombinant forms. 
Our results how that tRNA. by affecting the enzyme 
activity, is able to interact with this recombinant form. 
The effect of tRNA on the pSl/p51 form is similar to 
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that observed previously concerning the inieractions be- 
tween p66/p66 and p65/p51 with tRNALy‘. In the cast 
of the latter recombinant enzymes important strucurnl 
changes of the enzyme were induced by formalion of a 
complex with the specific primer tRNA. Work is in 
progress to isolate a complex tRNALs”-RT p5 I/p5 I and 
to study the topography of the interaction between 
tRNALr” and p5l/p51, as well as the other RT recom- 
binant forms used in this work. 
A~~,~o~~,(cll~s~~/rler~~s,. The tiuthors a e wry grateful 11) Dr. Michcl 
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